Global Pediatric Obesity Management Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Pediatric Obesity Management market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pediatric Obesity Management is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pediatric Obesity Management is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pediatric Obesity Management is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pediatric Obesity Management players cover Pfizer, F.Hoffmann-La Roche, GlaxoSmithKline, AstraZeneca,, Herbalife, ApolloEndosurgery, Ethicon, Inc., Takeda Pharmaceutical Company and VIVUS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Pediatric Obesity Management Industry Forecast” looks at past sales and reviews total world Pediatric Obesity Management sales in 2022, providing a comprehensive analysis by region and market sector of projected Pediatric Obesity Management sales for 2023 through 2029. With Pediatric Obesity Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Obesity Management industry.
This Insight Report provides a comprehensive analysis of the global Pediatric Obesity Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric Obesity Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pediatric Obesity Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric Obesity Management and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric Obesity Management.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Obesity Management market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pediatric Obesity Management market?
What factors are driving Pediatric Obesity Management market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pediatric Obesity Management market opportunities vary by end market size?
How does Pediatric Obesity Management break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Pediatric Obesity Management market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pediatric Obesity Management is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pediatric Obesity Management is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pediatric Obesity Management is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pediatric Obesity Management players cover Pfizer, F.Hoffmann-La Roche, GlaxoSmithKline, AstraZeneca,, Herbalife, ApolloEndosurgery, Ethicon, Inc., Takeda Pharmaceutical Company and VIVUS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Pediatric Obesity Management Industry Forecast” looks at past sales and reviews total world Pediatric Obesity Management sales in 2022, providing a comprehensive analysis by region and market sector of projected Pediatric Obesity Management sales for 2023 through 2029. With Pediatric Obesity Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Obesity Management industry.
This Insight Report provides a comprehensive analysis of the global Pediatric Obesity Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric Obesity Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pediatric Obesity Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric Obesity Management and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric Obesity Management.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Obesity Management market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Lorcaserin
- Liraglutide
- Phentermine
- Setmelanotide
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- F.Hoffmann-La Roche
- GlaxoSmithKline
- AstraZeneca,
- Herbalife
- ApolloEndosurgery
- Ethicon, Inc.
- Takeda Pharmaceutical Company
- VIVUS
- Currax Pharmaceuticals
What is the 10-year outlook for the global Pediatric Obesity Management market?
What factors are driving Pediatric Obesity Management market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pediatric Obesity Management market opportunities vary by end market size?
How does Pediatric Obesity Management break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pediatric Obesity Management Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pediatric Obesity Management by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pediatric Obesity Management by Country/Region, 2018, 2022 & 2029
2.2 Pediatric Obesity Management Segment by Type
2.2.1 Lorcaserin
2.2.2 Liraglutide
2.2.3 Phentermine
2.2.4 Setmelanotide
2.2.5 Others
2.3 Pediatric Obesity Management Sales by Type
2.3.1 Global Pediatric Obesity Management Sales Market Share by Type (2018-2023)
2.3.2 Global Pediatric Obesity Management Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pediatric Obesity Management Sale Price by Type (2018-2023)
2.4 Pediatric Obesity Management Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Pediatric Obesity Management Sales by Application
2.5.1 Global Pediatric Obesity Management Sale Market Share by Application (2018-2023)
2.5.2 Global Pediatric Obesity Management Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pediatric Obesity Management Sale Price by Application (2018-2023)
3 GLOBAL PEDIATRIC OBESITY MANAGEMENT BY COMPANY
3.1 Global Pediatric Obesity Management Breakdown Data by Company
3.1.1 Global Pediatric Obesity Management Annual Sales by Company (2018-2023)
3.1.2 Global Pediatric Obesity Management Sales Market Share by Company (2018-2023)
3.2 Global Pediatric Obesity Management Annual Revenue by Company (2018-2023)
3.2.1 Global Pediatric Obesity Management Revenue by Company (2018-2023)
3.2.2 Global Pediatric Obesity Management Revenue Market Share by Company (2018-2023)
3.3 Global Pediatric Obesity Management Sale Price by Company
3.4 Key Manufacturers Pediatric Obesity Management Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pediatric Obesity Management Product Location Distribution
3.4.2 Players Pediatric Obesity Management Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PEDIATRIC OBESITY MANAGEMENT BY GEOGRAPHIC REGION
4.1 World Historic Pediatric Obesity Management Market Size by Geographic Region (2018-2023)
4.1.1 Global Pediatric Obesity Management Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pediatric Obesity Management Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pediatric Obesity Management Market Size by Country/Region (2018-2023)
4.2.1 Global Pediatric Obesity Management Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pediatric Obesity Management Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pediatric Obesity Management Sales Growth
4.4 APAC Pediatric Obesity Management Sales Growth
4.5 Europe Pediatric Obesity Management Sales Growth
4.6 Middle East & Africa Pediatric Obesity Management Sales Growth
5 AMERICAS
5.1 Americas Pediatric Obesity Management Sales by Country
5.1.1 Americas Pediatric Obesity Management Sales by Country (2018-2023)
5.1.2 Americas Pediatric Obesity Management Revenue by Country (2018-2023)
5.2 Americas Pediatric Obesity Management Sales by Type
5.3 Americas Pediatric Obesity Management Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Obesity Management Sales by Region
6.1.1 APAC Pediatric Obesity Management Sales by Region (2018-2023)
6.1.2 APAC Pediatric Obesity Management Revenue by Region (2018-2023)
6.2 APAC Pediatric Obesity Management Sales by Type
6.3 APAC Pediatric Obesity Management Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pediatric Obesity Management by Country
7.1.1 Europe Pediatric Obesity Management Sales by Country (2018-2023)
7.1.2 Europe Pediatric Obesity Management Revenue by Country (2018-2023)
7.2 Europe Pediatric Obesity Management Sales by Type
7.3 Europe Pediatric Obesity Management Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pediatric Obesity Management by Country
8.1.1 Middle East & Africa Pediatric Obesity Management Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pediatric Obesity Management Revenue by Country (2018-2023)
8.2 Middle East & Africa Pediatric Obesity Management Sales by Type
8.3 Middle East & Africa Pediatric Obesity Management Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pediatric Obesity Management
10.3 Manufacturing Process Analysis of Pediatric Obesity Management
10.4 Industry Chain Structure of Pediatric Obesity Management
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pediatric Obesity Management Distributors
11.3 Pediatric Obesity Management Customer
12 WORLD FORECAST REVIEW FOR PEDIATRIC OBESITY MANAGEMENT BY GEOGRAPHIC REGION
12.1 Global Pediatric Obesity Management Market Size Forecast by Region
12.1.1 Global Pediatric Obesity Management Forecast by Region (2024-2029)
12.1.2 Global Pediatric Obesity Management Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pediatric Obesity Management Forecast by Type
12.7 Global Pediatric Obesity Management Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pediatric Obesity Management Product Portfolios and Specifications
13.1.3 Pfizer Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Information
13.2.2 F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolios and Specifications
13.2.3 F.Hoffmann-La Roche Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 F.Hoffmann-La Roche Main Business Overview
13.2.5 F.Hoffmann-La Roche Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Pediatric Obesity Management Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 AstraZeneca,
13.4.1 AstraZeneca, Company Information
13.4.2 AstraZeneca, Pediatric Obesity Management Product Portfolios and Specifications
13.4.3 AstraZeneca, Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca, Main Business Overview
13.4.5 AstraZeneca, Latest Developments
13.5 Herbalife
13.5.1 Herbalife Company Information
13.5.2 Herbalife Pediatric Obesity Management Product Portfolios and Specifications
13.5.3 Herbalife Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Herbalife Main Business Overview
13.5.5 Herbalife Latest Developments
13.6 ApolloEndosurgery
13.6.1 ApolloEndosurgery Company Information
13.6.2 ApolloEndosurgery Pediatric Obesity Management Product Portfolios and Specifications
13.6.3 ApolloEndosurgery Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ApolloEndosurgery Main Business Overview
13.6.5 ApolloEndosurgery Latest Developments
13.7 Ethicon, Inc.
13.7.1 Ethicon, Inc. Company Information
13.7.2 Ethicon, Inc. Pediatric Obesity Management Product Portfolios and Specifications
13.7.3 Ethicon, Inc. Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ethicon, Inc. Main Business Overview
13.7.5 Ethicon, Inc. Latest Developments
13.8 Takeda Pharmaceutical Company
13.8.1 Takeda Pharmaceutical Company Company Information
13.8.2 Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolios and Specifications
13.8.3 Takeda Pharmaceutical Company Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Takeda Pharmaceutical Company Main Business Overview
13.8.5 Takeda Pharmaceutical Company Latest Developments
13.9 VIVUS
13.9.1 VIVUS Company Information
13.9.2 VIVUS Pediatric Obesity Management Product Portfolios and Specifications
13.9.3 VIVUS Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 VIVUS Main Business Overview
13.9.5 VIVUS Latest Developments
13.10 Currax Pharmaceuticals
13.10.1 Currax Pharmaceuticals Company Information
13.10.2 Currax Pharmaceuticals Pediatric Obesity Management Product Portfolios and Specifications
13.10.3 Currax Pharmaceuticals Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Currax Pharmaceuticals Main Business Overview
13.10.5 Currax Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pediatric Obesity Management Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pediatric Obesity Management by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pediatric Obesity Management by Country/Region, 2018, 2022 & 2029
2.2 Pediatric Obesity Management Segment by Type
2.2.1 Lorcaserin
2.2.2 Liraglutide
2.2.3 Phentermine
2.2.4 Setmelanotide
2.2.5 Others
2.3 Pediatric Obesity Management Sales by Type
2.3.1 Global Pediatric Obesity Management Sales Market Share by Type (2018-2023)
2.3.2 Global Pediatric Obesity Management Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pediatric Obesity Management Sale Price by Type (2018-2023)
2.4 Pediatric Obesity Management Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Pediatric Obesity Management Sales by Application
2.5.1 Global Pediatric Obesity Management Sale Market Share by Application (2018-2023)
2.5.2 Global Pediatric Obesity Management Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pediatric Obesity Management Sale Price by Application (2018-2023)
3 GLOBAL PEDIATRIC OBESITY MANAGEMENT BY COMPANY
3.1 Global Pediatric Obesity Management Breakdown Data by Company
3.1.1 Global Pediatric Obesity Management Annual Sales by Company (2018-2023)
3.1.2 Global Pediatric Obesity Management Sales Market Share by Company (2018-2023)
3.2 Global Pediatric Obesity Management Annual Revenue by Company (2018-2023)
3.2.1 Global Pediatric Obesity Management Revenue by Company (2018-2023)
3.2.2 Global Pediatric Obesity Management Revenue Market Share by Company (2018-2023)
3.3 Global Pediatric Obesity Management Sale Price by Company
3.4 Key Manufacturers Pediatric Obesity Management Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pediatric Obesity Management Product Location Distribution
3.4.2 Players Pediatric Obesity Management Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PEDIATRIC OBESITY MANAGEMENT BY GEOGRAPHIC REGION
4.1 World Historic Pediatric Obesity Management Market Size by Geographic Region (2018-2023)
4.1.1 Global Pediatric Obesity Management Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pediatric Obesity Management Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pediatric Obesity Management Market Size by Country/Region (2018-2023)
4.2.1 Global Pediatric Obesity Management Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pediatric Obesity Management Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pediatric Obesity Management Sales Growth
4.4 APAC Pediatric Obesity Management Sales Growth
4.5 Europe Pediatric Obesity Management Sales Growth
4.6 Middle East & Africa Pediatric Obesity Management Sales Growth
5 AMERICAS
5.1 Americas Pediatric Obesity Management Sales by Country
5.1.1 Americas Pediatric Obesity Management Sales by Country (2018-2023)
5.1.2 Americas Pediatric Obesity Management Revenue by Country (2018-2023)
5.2 Americas Pediatric Obesity Management Sales by Type
5.3 Americas Pediatric Obesity Management Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Obesity Management Sales by Region
6.1.1 APAC Pediatric Obesity Management Sales by Region (2018-2023)
6.1.2 APAC Pediatric Obesity Management Revenue by Region (2018-2023)
6.2 APAC Pediatric Obesity Management Sales by Type
6.3 APAC Pediatric Obesity Management Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pediatric Obesity Management by Country
7.1.1 Europe Pediatric Obesity Management Sales by Country (2018-2023)
7.1.2 Europe Pediatric Obesity Management Revenue by Country (2018-2023)
7.2 Europe Pediatric Obesity Management Sales by Type
7.3 Europe Pediatric Obesity Management Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pediatric Obesity Management by Country
8.1.1 Middle East & Africa Pediatric Obesity Management Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pediatric Obesity Management Revenue by Country (2018-2023)
8.2 Middle East & Africa Pediatric Obesity Management Sales by Type
8.3 Middle East & Africa Pediatric Obesity Management Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pediatric Obesity Management
10.3 Manufacturing Process Analysis of Pediatric Obesity Management
10.4 Industry Chain Structure of Pediatric Obesity Management
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pediatric Obesity Management Distributors
11.3 Pediatric Obesity Management Customer
12 WORLD FORECAST REVIEW FOR PEDIATRIC OBESITY MANAGEMENT BY GEOGRAPHIC REGION
12.1 Global Pediatric Obesity Management Market Size Forecast by Region
12.1.1 Global Pediatric Obesity Management Forecast by Region (2024-2029)
12.1.2 Global Pediatric Obesity Management Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pediatric Obesity Management Forecast by Type
12.7 Global Pediatric Obesity Management Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pediatric Obesity Management Product Portfolios and Specifications
13.1.3 Pfizer Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 F.Hoffmann-La Roche
13.2.1 F.Hoffmann-La Roche Company Information
13.2.2 F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolios and Specifications
13.2.3 F.Hoffmann-La Roche Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 F.Hoffmann-La Roche Main Business Overview
13.2.5 F.Hoffmann-La Roche Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Pediatric Obesity Management Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 AstraZeneca,
13.4.1 AstraZeneca, Company Information
13.4.2 AstraZeneca, Pediatric Obesity Management Product Portfolios and Specifications
13.4.3 AstraZeneca, Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca, Main Business Overview
13.4.5 AstraZeneca, Latest Developments
13.5 Herbalife
13.5.1 Herbalife Company Information
13.5.2 Herbalife Pediatric Obesity Management Product Portfolios and Specifications
13.5.3 Herbalife Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Herbalife Main Business Overview
13.5.5 Herbalife Latest Developments
13.6 ApolloEndosurgery
13.6.1 ApolloEndosurgery Company Information
13.6.2 ApolloEndosurgery Pediatric Obesity Management Product Portfolios and Specifications
13.6.3 ApolloEndosurgery Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ApolloEndosurgery Main Business Overview
13.6.5 ApolloEndosurgery Latest Developments
13.7 Ethicon, Inc.
13.7.1 Ethicon, Inc. Company Information
13.7.2 Ethicon, Inc. Pediatric Obesity Management Product Portfolios and Specifications
13.7.3 Ethicon, Inc. Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ethicon, Inc. Main Business Overview
13.7.5 Ethicon, Inc. Latest Developments
13.8 Takeda Pharmaceutical Company
13.8.1 Takeda Pharmaceutical Company Company Information
13.8.2 Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolios and Specifications
13.8.3 Takeda Pharmaceutical Company Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Takeda Pharmaceutical Company Main Business Overview
13.8.5 Takeda Pharmaceutical Company Latest Developments
13.9 VIVUS
13.9.1 VIVUS Company Information
13.9.2 VIVUS Pediatric Obesity Management Product Portfolios and Specifications
13.9.3 VIVUS Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 VIVUS Main Business Overview
13.9.5 VIVUS Latest Developments
13.10 Currax Pharmaceuticals
13.10.1 Currax Pharmaceuticals Company Information
13.10.2 Currax Pharmaceuticals Pediatric Obesity Management Product Portfolios and Specifications
13.10.3 Currax Pharmaceuticals Pediatric Obesity Management Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Currax Pharmaceuticals Main Business Overview
13.10.5 Currax Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pediatric Obesity Management Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pediatric Obesity Management Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Lorcaserin
Table 4. Major Players of Liraglutide
Table 5. Major Players of Phentermine
Table 6. Major Players of Setmelanotide
Table 7. Major Players of Others
Table 8. Global Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 9. Global Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Table 10. Global Pediatric Obesity Management Revenue by Type (2018-2023) & ($ million)
Table 11. Global Pediatric Obesity Management Revenue Market Share by Type (2018-2023)
Table 12. Global Pediatric Obesity Management Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 14. Global Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Table 15. Global Pediatric Obesity Management Revenue by Application (2018-2023)
Table 16. Global Pediatric Obesity Management Revenue Market Share by Application (2018-2023)
Table 17. Global Pediatric Obesity Management Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Pediatric Obesity Management Sales by Company (2018-2023) & (K Units)
Table 19. Global Pediatric Obesity Management Sales Market Share by Company (2018-2023)
Table 20. Global Pediatric Obesity Management Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Pediatric Obesity Management Revenue Market Share by Company (2018-2023)
Table 22. Global Pediatric Obesity Management Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Pediatric Obesity Management Producing Area Distribution and Sales Area
Table 24. Players Pediatric Obesity Management Products Offered
Table 25. Pediatric Obesity Management Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Pediatric Obesity Management Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Pediatric Obesity Management Sales Market Share Geographic Region (2018-2023)
Table 30. Global Pediatric Obesity Management Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Pediatric Obesity Management Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Pediatric Obesity Management Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Pediatric Obesity Management Sales Market Share by Country/Region (2018-2023)
Table 34. Global Pediatric Obesity Management Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Pediatric Obesity Management Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Pediatric Obesity Management Sales by Country (2018-2023) & (K Units)
Table 37. Americas Pediatric Obesity Management Sales Market Share by Country (2018-2023)
Table 38. Americas Pediatric Obesity Management Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Pediatric Obesity Management Revenue Market Share by Country (2018-2023)
Table 40. Americas Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 41. Americas Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 42. APAC Pediatric Obesity Management Sales by Region (2018-2023) & (K Units)
Table 43. APAC Pediatric Obesity Management Sales Market Share by Region (2018-2023)
Table 44. APAC Pediatric Obesity Management Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Pediatric Obesity Management Revenue Market Share by Region (2018-2023)
Table 46. APAC Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 47. APAC Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 48. Europe Pediatric Obesity Management Sales by Country (2018-2023) & (K Units)
Table 49. Europe Pediatric Obesity Management Sales Market Share by Country (2018-2023)
Table 50. Europe Pediatric Obesity Management Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Pediatric Obesity Management Revenue Market Share by Country (2018-2023)
Table 52. Europe Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 53. Europe Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Pediatric Obesity Management Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Pediatric Obesity Management Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pediatric Obesity Management Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Pediatric Obesity Management Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Pediatric Obesity Management
Table 61. Key Market Challenges & Risks of Pediatric Obesity Management
Table 62. Key Industry Trends of Pediatric Obesity Management
Table 63. Pediatric Obesity Management Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Pediatric Obesity Management Distributors List
Table 66. Pediatric Obesity Management Customer List
Table 67. Global Pediatric Obesity Management Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Pediatric Obesity Management Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Pediatric Obesity Management Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Pediatric Obesity Management Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Pediatric Obesity Management Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Pediatric Obesity Management Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Pediatric Obesity Management Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Pediatric Obesity Management Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Pediatric Obesity Management Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Pediatric Obesity Management Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Pediatric Obesity Management Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Pediatric Obesity Management Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Pediatric Obesity Management Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Pediatric Obesity Management Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Pfizer Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer Pediatric Obesity Management Product Portfolios and Specifications
Table 83. Pfizer Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Pfizer Main Business
Table 85. Pfizer Latest Developments
Table 86. F.Hoffmann-La Roche Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 87. F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolios and Specifications
Table 88. F.Hoffmann-La Roche Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. F.Hoffmann-La Roche Main Business
Table 90. F.Hoffmann-La Roche Latest Developments
Table 91. GlaxoSmithKline Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 92. GlaxoSmithKline Pediatric Obesity Management Product Portfolios and Specifications
Table 93. GlaxoSmithKline Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. GlaxoSmithKline Main Business
Table 95. GlaxoSmithKline Latest Developments
Table 96. AstraZeneca, Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 97. AstraZeneca, Pediatric Obesity Management Product Portfolios and Specifications
Table 98. AstraZeneca, Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. AstraZeneca, Main Business
Table 100. AstraZeneca, Latest Developments
Table 101. Herbalife Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 102. Herbalife Pediatric Obesity Management Product Portfolios and Specifications
Table 103. Herbalife Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Herbalife Main Business
Table 105. Herbalife Latest Developments
Table 106. ApolloEndosurgery Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 107. ApolloEndosurgery Pediatric Obesity Management Product Portfolios and Specifications
Table 108. ApolloEndosurgery Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. ApolloEndosurgery Main Business
Table 110. ApolloEndosurgery Latest Developments
Table 111. Ethicon, Inc. Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 112. Ethicon, Inc. Pediatric Obesity Management Product Portfolios and Specifications
Table 113. Ethicon, Inc. Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Ethicon, Inc. Main Business
Table 115. Ethicon, Inc. Latest Developments
Table 116. Takeda Pharmaceutical Company Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 117. Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolios and Specifications
Table 118. Takeda Pharmaceutical Company Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Takeda Pharmaceutical Company Main Business
Table 120. Takeda Pharmaceutical Company Latest Developments
Table 121. VIVUS Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 122. VIVUS Pediatric Obesity Management Product Portfolios and Specifications
Table 123. VIVUS Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. VIVUS Main Business
Table 125. VIVUS Latest Developments
Table 126. Currax Pharmaceuticals Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 127. Currax Pharmaceuticals Pediatric Obesity Management Product Portfolios and Specifications
Table 128. Currax Pharmaceuticals Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Currax Pharmaceuticals Main Business
Table 130. Currax Pharmaceuticals Latest Developments
Table 1. Pediatric Obesity Management Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pediatric Obesity Management Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Lorcaserin
Table 4. Major Players of Liraglutide
Table 5. Major Players of Phentermine
Table 6. Major Players of Setmelanotide
Table 7. Major Players of Others
Table 8. Global Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 9. Global Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Table 10. Global Pediatric Obesity Management Revenue by Type (2018-2023) & ($ million)
Table 11. Global Pediatric Obesity Management Revenue Market Share by Type (2018-2023)
Table 12. Global Pediatric Obesity Management Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 14. Global Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Table 15. Global Pediatric Obesity Management Revenue by Application (2018-2023)
Table 16. Global Pediatric Obesity Management Revenue Market Share by Application (2018-2023)
Table 17. Global Pediatric Obesity Management Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Pediatric Obesity Management Sales by Company (2018-2023) & (K Units)
Table 19. Global Pediatric Obesity Management Sales Market Share by Company (2018-2023)
Table 20. Global Pediatric Obesity Management Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Pediatric Obesity Management Revenue Market Share by Company (2018-2023)
Table 22. Global Pediatric Obesity Management Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Pediatric Obesity Management Producing Area Distribution and Sales Area
Table 24. Players Pediatric Obesity Management Products Offered
Table 25. Pediatric Obesity Management Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Pediatric Obesity Management Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Pediatric Obesity Management Sales Market Share Geographic Region (2018-2023)
Table 30. Global Pediatric Obesity Management Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Pediatric Obesity Management Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Pediatric Obesity Management Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Pediatric Obesity Management Sales Market Share by Country/Region (2018-2023)
Table 34. Global Pediatric Obesity Management Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Pediatric Obesity Management Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Pediatric Obesity Management Sales by Country (2018-2023) & (K Units)
Table 37. Americas Pediatric Obesity Management Sales Market Share by Country (2018-2023)
Table 38. Americas Pediatric Obesity Management Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Pediatric Obesity Management Revenue Market Share by Country (2018-2023)
Table 40. Americas Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 41. Americas Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 42. APAC Pediatric Obesity Management Sales by Region (2018-2023) & (K Units)
Table 43. APAC Pediatric Obesity Management Sales Market Share by Region (2018-2023)
Table 44. APAC Pediatric Obesity Management Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Pediatric Obesity Management Revenue Market Share by Region (2018-2023)
Table 46. APAC Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 47. APAC Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 48. Europe Pediatric Obesity Management Sales by Country (2018-2023) & (K Units)
Table 49. Europe Pediatric Obesity Management Sales Market Share by Country (2018-2023)
Table 50. Europe Pediatric Obesity Management Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Pediatric Obesity Management Revenue Market Share by Country (2018-2023)
Table 52. Europe Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 53. Europe Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Pediatric Obesity Management Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Pediatric Obesity Management Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pediatric Obesity Management Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Pediatric Obesity Management Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Pediatric Obesity Management Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Pediatric Obesity Management Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Pediatric Obesity Management
Table 61. Key Market Challenges & Risks of Pediatric Obesity Management
Table 62. Key Industry Trends of Pediatric Obesity Management
Table 63. Pediatric Obesity Management Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Pediatric Obesity Management Distributors List
Table 66. Pediatric Obesity Management Customer List
Table 67. Global Pediatric Obesity Management Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Pediatric Obesity Management Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Pediatric Obesity Management Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Pediatric Obesity Management Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Pediatric Obesity Management Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Pediatric Obesity Management Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Pediatric Obesity Management Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Pediatric Obesity Management Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Pediatric Obesity Management Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Pediatric Obesity Management Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Pediatric Obesity Management Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Pediatric Obesity Management Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Pediatric Obesity Management Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Pediatric Obesity Management Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Pfizer Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer Pediatric Obesity Management Product Portfolios and Specifications
Table 83. Pfizer Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Pfizer Main Business
Table 85. Pfizer Latest Developments
Table 86. F.Hoffmann-La Roche Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 87. F.Hoffmann-La Roche Pediatric Obesity Management Product Portfolios and Specifications
Table 88. F.Hoffmann-La Roche Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. F.Hoffmann-La Roche Main Business
Table 90. F.Hoffmann-La Roche Latest Developments
Table 91. GlaxoSmithKline Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 92. GlaxoSmithKline Pediatric Obesity Management Product Portfolios and Specifications
Table 93. GlaxoSmithKline Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. GlaxoSmithKline Main Business
Table 95. GlaxoSmithKline Latest Developments
Table 96. AstraZeneca, Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 97. AstraZeneca, Pediatric Obesity Management Product Portfolios and Specifications
Table 98. AstraZeneca, Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. AstraZeneca, Main Business
Table 100. AstraZeneca, Latest Developments
Table 101. Herbalife Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 102. Herbalife Pediatric Obesity Management Product Portfolios and Specifications
Table 103. Herbalife Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Herbalife Main Business
Table 105. Herbalife Latest Developments
Table 106. ApolloEndosurgery Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 107. ApolloEndosurgery Pediatric Obesity Management Product Portfolios and Specifications
Table 108. ApolloEndosurgery Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. ApolloEndosurgery Main Business
Table 110. ApolloEndosurgery Latest Developments
Table 111. Ethicon, Inc. Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 112. Ethicon, Inc. Pediatric Obesity Management Product Portfolios and Specifications
Table 113. Ethicon, Inc. Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Ethicon, Inc. Main Business
Table 115. Ethicon, Inc. Latest Developments
Table 116. Takeda Pharmaceutical Company Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 117. Takeda Pharmaceutical Company Pediatric Obesity Management Product Portfolios and Specifications
Table 118. Takeda Pharmaceutical Company Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Takeda Pharmaceutical Company Main Business
Table 120. Takeda Pharmaceutical Company Latest Developments
Table 121. VIVUS Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 122. VIVUS Pediatric Obesity Management Product Portfolios and Specifications
Table 123. VIVUS Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. VIVUS Main Business
Table 125. VIVUS Latest Developments
Table 126. Currax Pharmaceuticals Basic Information, Pediatric Obesity Management Manufacturing Base, Sales Area and Its Competitors
Table 127. Currax Pharmaceuticals Pediatric Obesity Management Product Portfolios and Specifications
Table 128. Currax Pharmaceuticals Pediatric Obesity Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Currax Pharmaceuticals Main Business
Table 130. Currax Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pediatric Obesity Management
Figure 2. Pediatric Obesity Management Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Obesity Management Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pediatric Obesity Management Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pediatric Obesity Management Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Lorcaserin
Figure 10. Product Picture of Liraglutide
Figure 11. Product Picture of Phentermine
Figure 12. Product Picture of Setmelanotide
Figure 13. Product Picture of Others
Figure 14. Global Pediatric Obesity Management Sales Market Share by Type in 2022
Figure 15. Global Pediatric Obesity Management Revenue Market Share by Type (2018-2023)
Figure 16. Pediatric Obesity Management Consumed in Hospital Pharmacies
Figure 17. Global Pediatric Obesity Management Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 18. Pediatric Obesity Management Consumed in Retail Pharmacies
Figure 19. Global Pediatric Obesity Management Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 20. Pediatric Obesity Management Consumed in Online Pharmacies
Figure 21. Global Pediatric Obesity Management Market: Online Pharmacies (2018-2023) & (K Units)
Figure 22. Global Pediatric Obesity Management Sales Market Share by Application (2022)
Figure 23. Global Pediatric Obesity Management Revenue Market Share by Application in 2022
Figure 24. Pediatric Obesity Management Sales Market by Company in 2022 (K Units)
Figure 25. Global Pediatric Obesity Management Sales Market Share by Company in 2022
Figure 26. Pediatric Obesity Management Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Pediatric Obesity Management Revenue Market Share by Company in 2022
Figure 28. Global Pediatric Obesity Management Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Pediatric Obesity Management Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Pediatric Obesity Management Sales 2018-2023 (K Units)
Figure 31. Americas Pediatric Obesity Management Revenue 2018-2023 ($ Millions)
Figure 32. APAC Pediatric Obesity Management Sales 2018-2023 (K Units)
Figure 33. APAC Pediatric Obesity Management Revenue 2018-2023 ($ Millions)
Figure 34. Europe Pediatric Obesity Management Sales 2018-2023 (K Units)
Figure 35. Europe Pediatric Obesity Management Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Pediatric Obesity Management Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Pediatric Obesity Management Revenue 2018-2023 ($ Millions)
Figure 38. Americas Pediatric Obesity Management Sales Market Share by Country in 2022
Figure 39. Americas Pediatric Obesity Management Revenue Market Share by Country in 2022
Figure 40. Americas Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Figure 41. Americas Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Figure 42. United States Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Pediatric Obesity Management Sales Market Share by Region in 2022
Figure 47. APAC Pediatric Obesity Management Revenue Market Share by Regions in 2022
Figure 48. APAC Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Figure 49. APAC Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Figure 50. China Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Pediatric Obesity Management Sales Market Share by Country in 2022
Figure 58. Europe Pediatric Obesity Management Revenue Market Share by Country in 2022
Figure 59. Europe Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Figure 60. Europe Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Figure 61. Germany Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Pediatric Obesity Management Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Pediatric Obesity Management Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Figure 70. Egypt Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Pediatric Obesity Management in 2022
Figure 76. Manufacturing Process Analysis of Pediatric Obesity Management
Figure 77. Industry Chain Structure of Pediatric Obesity Management
Figure 78. Channels of Distribution
Figure 79. Global Pediatric Obesity Management Sales Market Forecast by Region (2024-2029)
Figure 80. Global Pediatric Obesity Management Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Pediatric Obesity Management Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Pediatric Obesity Management Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Pediatric Obesity Management Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Pediatric Obesity Management Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pediatric Obesity Management
Figure 2. Pediatric Obesity Management Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Obesity Management Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pediatric Obesity Management Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pediatric Obesity Management Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Lorcaserin
Figure 10. Product Picture of Liraglutide
Figure 11. Product Picture of Phentermine
Figure 12. Product Picture of Setmelanotide
Figure 13. Product Picture of Others
Figure 14. Global Pediatric Obesity Management Sales Market Share by Type in 2022
Figure 15. Global Pediatric Obesity Management Revenue Market Share by Type (2018-2023)
Figure 16. Pediatric Obesity Management Consumed in Hospital Pharmacies
Figure 17. Global Pediatric Obesity Management Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 18. Pediatric Obesity Management Consumed in Retail Pharmacies
Figure 19. Global Pediatric Obesity Management Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 20. Pediatric Obesity Management Consumed in Online Pharmacies
Figure 21. Global Pediatric Obesity Management Market: Online Pharmacies (2018-2023) & (K Units)
Figure 22. Global Pediatric Obesity Management Sales Market Share by Application (2022)
Figure 23. Global Pediatric Obesity Management Revenue Market Share by Application in 2022
Figure 24. Pediatric Obesity Management Sales Market by Company in 2022 (K Units)
Figure 25. Global Pediatric Obesity Management Sales Market Share by Company in 2022
Figure 26. Pediatric Obesity Management Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Pediatric Obesity Management Revenue Market Share by Company in 2022
Figure 28. Global Pediatric Obesity Management Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Pediatric Obesity Management Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Pediatric Obesity Management Sales 2018-2023 (K Units)
Figure 31. Americas Pediatric Obesity Management Revenue 2018-2023 ($ Millions)
Figure 32. APAC Pediatric Obesity Management Sales 2018-2023 (K Units)
Figure 33. APAC Pediatric Obesity Management Revenue 2018-2023 ($ Millions)
Figure 34. Europe Pediatric Obesity Management Sales 2018-2023 (K Units)
Figure 35. Europe Pediatric Obesity Management Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Pediatric Obesity Management Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Pediatric Obesity Management Revenue 2018-2023 ($ Millions)
Figure 38. Americas Pediatric Obesity Management Sales Market Share by Country in 2022
Figure 39. Americas Pediatric Obesity Management Revenue Market Share by Country in 2022
Figure 40. Americas Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Figure 41. Americas Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Figure 42. United States Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Pediatric Obesity Management Sales Market Share by Region in 2022
Figure 47. APAC Pediatric Obesity Management Revenue Market Share by Regions in 2022
Figure 48. APAC Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Figure 49. APAC Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Figure 50. China Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Pediatric Obesity Management Sales Market Share by Country in 2022
Figure 58. Europe Pediatric Obesity Management Revenue Market Share by Country in 2022
Figure 59. Europe Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Figure 60. Europe Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Figure 61. Germany Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Pediatric Obesity Management Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Pediatric Obesity Management Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Pediatric Obesity Management Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Pediatric Obesity Management Sales Market Share by Application (2018-2023)
Figure 70. Egypt Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Pediatric Obesity Management Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Pediatric Obesity Management in 2022
Figure 76. Manufacturing Process Analysis of Pediatric Obesity Management
Figure 77. Industry Chain Structure of Pediatric Obesity Management
Figure 78. Channels of Distribution
Figure 79. Global Pediatric Obesity Management Sales Market Forecast by Region (2024-2029)
Figure 80. Global Pediatric Obesity Management Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Pediatric Obesity Management Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Pediatric Obesity Management Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Pediatric Obesity Management Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Pediatric Obesity Management Revenue Market Share Forecast by Application (2024-2029)
